52448
Ranitidine S-oxide
pharmaceutical impurity standard, ≥95.0% (HPLC)
别名:
Ranitidine Related Compound C (USP), Ranitidine impurity C (PhEur), N-{2-{{{5-[(Dimethylamino)methyl]furan-2-yl}methyl}sulfinyl}ethyl}-N′-methyl-2-nitroethene-1,1-diamine
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C13H22N4O4S
化学文摘社编号:
分子量:
330.40
PubChem Substance ID:
UNSPSC Code:
41116107
Beilstein/REAXYS Number:
8395257
MDL number:
grade
analytical standard
assay
≥95.0% (HPLC)
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
impurities
≤10.0% related substances, ≤5.0% solvents, ≤5.0% water
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CN\C(NCCS(=O)Cc1ccc(CN(C)C)o1)=C/[N+]([O-])=O
InChI
1S/C13H22N4O4S/c1-14-13(9-17(18)19)15-6-7-22(20)10-12-5-4-11(21-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+
InChI key
SKHXRNHSZTXSLP-UKTHLTGXSA-N
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
M H Davies et al.
Journal of hepatology, 22(5), 551-560 (1995-05-01)
We have previously reported an association of impaired S-oxidation with primary biliary cirrhosis. In order to confirm and further define this relationship, we retested S-oxidation capacity via three metabolic pathways and sulphation capacity via a fourth pathway. Metabolism of S-carboxymethyl-L-cysteine
J H Kang et al.
Pharmacogenetics, 10(1), 67-78 (2000-03-30)
A non-invasive urine analysis method to determine the in-vivo flavin-containing mono-oxygenase (FMO) activity catalysing N-oxidation of ranitidine (RA) was developed and used to phenotype a Korean population. FMO activity was assessed by the molar concentration ratio of RA and RANO
M S Lant et al.
Journal of chromatography, 323(1), 143-152 (1985-04-17)
Reversed-phase high-performance liquid chromatography systems for the separation of ranitidine and its metabolites ranitidine-N-oxide, ranitidine-S-oxide, and desmethylranitidine have been developed for use in high-performance liquid chromatography-mass spectrometry. A direct liquid introduction-high-performance liquid chromatography-mass spectrometry system to analyse qualitatively and quantitatively